New stroke-prevention drug may replace warfarin for people with atrial fibrillation November 9, 2010Dr. Barry Dworkin Madely Health Headlines Commentary for November , 2010 [display_podcast] Source: Approval of new drug heralds ‘momentous’ advance in stroke prevention Reference: Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial – Lancet Neurology Related posts: New blood thinners add value to stroke prevention and quality of life FDA approval Xarelto for stroke prevention in atrial fibrillation patients questioned Silent atrial fibrillation a cause for strokes:study Study unable to show causation for increased stroke risk in first month of warfarin treatment for patients with atrial fibrillation atrial fibrillationcoumadindabigatranPradaxastrokewarfarin